Stock Market News

RBC upgrades Sandoz to “outperform,” sees 24% upside on biosimilar growth

May 2, 2025 - 13:37
 0
RBC upgrades Sandoz to “outperform,” sees 24% upside on biosimilar growth
Read More

Tags:

Previous Article

Is Allot Ltd. (ALLT) the Best Cybersecurity Stock to Invest in Under $20?

Next Article

British and Indian trade ministers near completion of proposed free trade deal

Related Posts

Adidas holds back on profit upgrade due to tariff uncertainty

Adidas holds back on profit upgrade due to tariff uncer...

Apr 29, 2025  0

Fort Bliss military base to accommodate migrant detainees, says Tom Homan

Fort Bliss military base to accommodate migrant detaine...

Apr 28, 2025  0

Akbank's 1Q25 profit rises, but Citi lowers stock estimates

Akbank's 1Q25 profit rises, but Citi lowers stock estim...

Apr 28, 2025  0